 | • レポートコード：D005-00515 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、体外診断/IVDの世界市場を広く調査・分析し、今後の市場展望をまとめております。体外診断/IVDの種類別市場規模（器具、試薬）、用途別市場規模（糖尿病、腫瘍学、循環器学、腎臓学）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche Diagnostics (Switzerland)、Sysmex Corporation (Japan)、Abbott Laboratories (US)、Siemens Healthineers (Germany)、Bio-Rad Laboratories (US)、Danaher Corporation (US)、DiaSorin (Italy)、Johnson and Johnson (US)、Thermo Fisher Scientific (US)、bioMérieux (France)、Ortho Clinical Diagnostics (US)、Agilent Technologies (US)、QIAGEN (Germany) ・地域別グローバル市場分析 2015年-2020年 ・体外診断/IVDの北米市場（アメリカ、カナダ、メキシコ） ・体外診断/IVDのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・体外診断/IVDのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・体外診断/IVDの南米市場（ブラジル、アルゼンチン） ・体外診断/IVDの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：器具、試薬 ・用途別分析：糖尿病、腫瘍学、循環器学、腎臓学 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global In Vitro Diagnostic/IVD market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The In Vitro Diagnostic/IVD market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
In Vitro Diagnostic/IVD market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, In Vitro Diagnostic/IVD market has been segmented into:
Instruments
Reagents
By Application, In Vitro Diagnostic/IVD has been segmented into:
Diabetes
Oncology
Cardiology
Nephrology
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global In Vitro Diagnostic/IVD market presented in the report. This section sheds light on the sales growth of different regional and country-level In Vitro Diagnostic/IVD markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global In Vitro Diagnostic/IVD market.
The report offers in-depth assessment of the growth and other aspects of the In Vitro Diagnostic/IVD market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and In Vitro Diagnostic/IVD Market Share Analysis
In Vitro Diagnostic/IVD competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, In Vitro Diagnostic/IVD sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the In Vitro Diagnostic/IVD sales, revenue and market share for each player covered in this report.
The major players covered in In Vitro Diagnostic/IVD are:
Roche Diagnostics (Switzerland)
Sysmex Corporation (Japan)
Abbott Laboratories (US)
Siemens Healthineers (Germany)
Bio-Rad Laboratories (US)
Danaher Corporation (US)
DiaSorin (Italy)
Johnson and Johnson (US)
Thermo Fisher Scientific (US)
bioMérieux (France)
Ortho Clinical Diagnostics (US)
Agilent Technologies (US)
QIAGEN (Germany)
Table of Contents
1 In Vitro Diagnostic/IVD Market Overview
1.1 Product Overview and Scope of In Vitro Diagnostic/IVD
1.2 Classification of In Vitro Diagnostic/IVD by Type
1.2.1 Global In Vitro Diagnostic/IVD Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global In Vitro Diagnostic/IVD Revenue Market Share by Type in 2019
1.2.3 Instruments
1.2.4 Reagents
1.3 Global In Vitro Diagnostic/IVD Market by Application
1.3.1 Overview: Global In Vitro Diagnostic/IVD Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diabetes
1.3.3 Oncology
1.3.4 Cardiology
1.3.5 Nephrology
1.4 Global In Vitro Diagnostic/IVD Market by Regions
1.4.1 Global In Vitro Diagnostic/IVD Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of In Vitro Diagnostic/IVD (2015-2025)
1.4.3 North America (USA, Canada and Mexico) In Vitro Diagnostic/IVD Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) In Vitro Diagnostic/IVD Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) In Vitro Diagnostic/IVD Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) In Vitro Diagnostic/IVD Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) In Vitro Diagnostic/IVD Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche Diagnostics (Switzerland)
2.1.1 Roche Diagnostics (Switzerland) Details
2.1.2 Roche Diagnostics (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche Diagnostics (Switzerland) SWOT Analysis
2.1.4 Roche Diagnostics (Switzerland) Product and Services
2.1.5 Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sysmex Corporation (Japan)
2.2.1 Sysmex Corporation (Japan) Details
2.2.2 Sysmex Corporation (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sysmex Corporation (Japan) SWOT Analysis
2.2.4 Sysmex Corporation (Japan) Product and Services
2.2.5 Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott Laboratories (US)
2.3.1 Abbott Laboratories (US) Details
2.3.2 Abbott Laboratories (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott Laboratories (US) SWOT Analysis
2.3.4 Abbott Laboratories (US) Product and Services
2.3.5 Abbott Laboratories (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.4 Siemens Healthineers (Germany)
2.4.1 Siemens Healthineers (Germany) Details
2.4.2 Siemens Healthineers (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Siemens Healthineers (Germany) SWOT Analysis
2.4.4 Siemens Healthineers (Germany) Product and Services
2.4.5 Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bio-Rad Laboratories (US)
2.5.1 Bio-Rad Laboratories (US) Details
2.5.2 Bio-Rad Laboratories (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bio-Rad Laboratories (US) SWOT Analysis
2.5.4 Bio-Rad Laboratories (US) Product and Services
2.5.5 Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.6 Danaher Corporation (US)
2.6.1 Danaher Corporation (US) Details
2.6.2 Danaher Corporation (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Danaher Corporation (US) SWOT Analysis
2.6.4 Danaher Corporation (US) Product and Services
2.6.5 Danaher Corporation (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.7 DiaSorin (Italy)
2.7.1 DiaSorin (Italy) Details
2.7.2 DiaSorin (Italy) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 DiaSorin (Italy) SWOT Analysis
2.7.4 DiaSorin (Italy) Product and Services
2.7.5 DiaSorin (Italy) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson and Johnson (US)
2.8.1 Johnson and Johnson (US) Details
2.8.2 Johnson and Johnson (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson and Johnson (US) SWOT Analysis
2.8.4 Johnson and Johnson (US) Product and Services
2.8.5 Johnson and Johnson (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.9 Thermo Fisher Scientific (US)
2.9.1 Thermo Fisher Scientific (US) Details
2.9.2 Thermo Fisher Scientific (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Thermo Fisher Scientific (US) SWOT Analysis
2.9.4 Thermo Fisher Scientific (US) Product and Services
2.9.5 Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.10 bioMérieux (France)
2.10.1 bioMérieux (France) Details
2.10.2 bioMérieux (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 bioMérieux (France) SWOT Analysis
2.10.4 bioMérieux (France) Product and Services
2.10.5 bioMérieux (France) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.11 Ortho Clinical Diagnostics (US)
2.11.1 Ortho Clinical Diagnostics (US) Details
2.11.2 Ortho Clinical Diagnostics (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Ortho Clinical Diagnostics (US) SWOT Analysis
2.11.4 Ortho Clinical Diagnostics (US) Product and Services
2.11.5 Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.12 Agilent Technologies (US)
2.12.1 Agilent Technologies (US) Details
2.12.2 Agilent Technologies (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Agilent Technologies (US) SWOT Analysis
2.12.4 Agilent Technologies (US) Product and Services
2.12.5 Agilent Technologies (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.13 QIAGEN (Germany)
2.13.1 QIAGEN (Germany) Details
2.13.2 QIAGEN (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 QIAGEN (Germany) SWOT Analysis
2.13.4 QIAGEN (Germany) Product and Services
2.13.5 QIAGEN (Germany) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global In Vitro Diagnostic/IVD Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 In Vitro Diagnostic/IVD Players Market Share
3.2.2 Top 10 In Vitro Diagnostic/IVD Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global In Vitro Diagnostic/IVD Revenue and Market Share by Regions
4.2 North America In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
4.3 Europe In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
4.5 South America In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
5 North America In Vitro Diagnostic/IVD Revenue by Countries
5.1 North America In Vitro Diagnostic/IVD Revenue by Countries (2015-2020)
5.2 USA In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
5.3 Canada In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
5.4 Mexico In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
6 Europe In Vitro Diagnostic/IVD Revenue by Countries
6.1 Europe In Vitro Diagnostic/IVD Revenue by Countries (2015-2020)
6.2 Germany In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
6.3 UK In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
6.4 France In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
6.5 Russia In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
6.6 Italy In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
7 Asia-Pacific In Vitro Diagnostic/IVD Revenue by Countries
7.1 Asia-Pacific In Vitro Diagnostic/IVD Revenue by Countries (2015-2020)
7.2 China In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
7.3 Japan In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
7.4 Korea In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
7.5 India In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
8 South America In Vitro Diagnostic/IVD Revenue by Countries
8.1 South America In Vitro Diagnostic/IVD Revenue by Countries (2015-2020)
8.2 Brazil In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
8.3 Argentina In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue In Vitro Diagnostic/IVD by Countries
9.1 Middle East & Africa In Vitro Diagnostic/IVD Revenue by Countries (2015-2020)
9.2 Saudi Arabia In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
9.3 UAE In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
9.4 Egypt In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
9.5 South Africa In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global In Vitro Diagnostic/IVD Revenue and Market Share by Type (2015-2020)
10.2 Global In Vitro Diagnostic/IVD Market Forecast by Type (2019-2024)
10.3 Instruments Revenue Growth Rate (2015-2025)
10.4 Reagents Revenue Growth Rate (2015-2025)
11 Global In Vitro Diagnostic/IVD Market Segment by Application
11.1 Global In Vitro Diagnostic/IVD Revenue Market Share by Application (2015-2020)
11.2 In Vitro Diagnostic/IVD Market Forecast by Application (2019-2024)
11.3 Diabetes Revenue Growth (2015-2020)
11.4 Oncology Revenue Growth (2015-2020)
11.5 Cardiology Revenue Growth (2015-2020)
11.6 Nephrology Revenue Growth (2015-2020)
12 Global In Vitro Diagnostic/IVD Market Size Forecast (2021-2025)
12.1 Global In Vitro Diagnostic/IVD Market Size Forecast (2021-2025)
12.2 Global In Vitro Diagnostic/IVD Market Forecast by Regions (2021-2025)
12.3 North America In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)
12.4 Europe In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)
12.6 South America In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global In Vitro Diagnostic/IVD Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of In Vitro Diagnostic/IVD by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global In Vitro Diagnostic/IVD Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market In Vitro Diagnostic/IVD Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Diagnostics (Switzerland) Corporate Information, Location and Competitors
Table 6. Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Major Business
Table 7. Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 8. Roche Diagnostics (Switzerland) SWOT Analysis
Table 9. Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Product and Solutions
Table 10. Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sysmex Corporation (Japan) Corporate Information, Location and Competitors
Table 12. Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Major Business
Table 13. Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2018-2019)
Table 14. Sysmex Corporation (Japan) SWOT Analysis
Table 15. Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Product and Solutions
Table 16. Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Abbott Laboratories (US) Corporate Information, Location and Competitors
Table 18. Abbott Laboratories (US) In Vitro Diagnostic/IVD Major Business
Table 19. Abbott Laboratories (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 20. Abbott Laboratories (US) SWOT Analysis
Table 21. Abbott Laboratories (US) In Vitro Diagnostic/IVD Product and Solutions
Table 22. Abbott Laboratories (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Siemens Healthineers (Germany) Corporate Information, Location and Competitors
Table 24. Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Major Business
Table 25. Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 26. Siemens Healthineers (Germany) SWOT Analysis
Table 27. Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Product and Solutions
Table 28. Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Bio-Rad Laboratories (US) Corporate Information, Location and Competitors
Table 30. Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Major Business
Table 31. Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 32. Bio-Rad Laboratories (US) SWOT Analysis
Table 33. Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Product and Solutions
Table 34. Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Danaher Corporation (US) Corporate Information, Location and Competitors
Table 36. Danaher Corporation (US) In Vitro Diagnostic/IVD Major Business
Table 37. Danaher Corporation (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 38. Danaher Corporation (US) SWOT Analysis
Table 39. Danaher Corporation (US) In Vitro Diagnostic/IVD Product and Solutions
Table 40. Danaher Corporation (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. DiaSorin (Italy) Corporate Information, Location and Competitors
Table 42. DiaSorin (Italy) In Vitro Diagnostic/IVD Major Business
Table 43. DiaSorin (Italy) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 44. DiaSorin (Italy) SWOT Analysis
Table 45. DiaSorin (Italy) In Vitro Diagnostic/IVD Product and Solutions
Table 46. DiaSorin (Italy) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Johnson and Johnson (US) Corporate Information, Location and Competitors
Table 48. Johnson and Johnson (US) In Vitro Diagnostic/IVD Major Business
Table 49. Johnson and Johnson (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 50. Johnson and Johnson (US) SWOT Analysis
Table 51. Johnson and Johnson (US) In Vitro Diagnostic/IVD Product and Solutions
Table 52. Johnson and Johnson (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Thermo Fisher Scientific (US) Corporate Information, Location and Competitors
Table 54. Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Major Business
Table 55. Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 56. Thermo Fisher Scientific (US) SWOT Analysis
Table 57. Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Product and Solutions
Table 58. Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. bioMérieux (France) Corporate Information, Location and Competitors
Table 60. bioMérieux (France) In Vitro Diagnostic/IVD Major Business
Table 61. bioMérieux (France) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 62. bioMérieux (France) SWOT Analysis
Table 63. bioMérieux (France) In Vitro Diagnostic/IVD Product and Solutions
Table 64. bioMérieux (France) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Ortho Clinical Diagnostics (US) Corporate Information, Location and Competitors
Table 66. Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Major Business
Table 67. Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 68. Ortho Clinical Diagnostics (US) SWOT Analysis
Table 69. Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Product and Solutions
Table 70. Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Agilent Technologies (US) Corporate Information, Location and Competitors
Table 72. Agilent Technologies (US) In Vitro Diagnostic/IVD Major Business
Table 73. Agilent Technologies (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 74. Agilent Technologies (US) SWOT Analysis
Table 75. Agilent Technologies (US) In Vitro Diagnostic/IVD Product and Solutions
Table 76. Agilent Technologies (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. QIAGEN (Germany) Corporate Information, Location and Competitors
Table 78. QIAGEN (Germany) In Vitro Diagnostic/IVD Major Business
Table 79. QIAGEN (Germany) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 80. QIAGEN (Germany) SWOT Analysis
Table 81. QIAGEN (Germany) In Vitro Diagnostic/IVD Product and Solutions
Table 82. QIAGEN (Germany) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global In Vitro Diagnostic/IVD Revenue (Million USD) by Players (2015-2020)
Table 84. Global In Vitro Diagnostic/IVD Revenue Share by Players (2015-2020)
Table 85. Global In Vitro Diagnostic/IVD Revenue (Million USD) by Regions (2015-2020)
Table 86. Global In Vitro Diagnostic/IVD Revenue Market Share by Regions (2015-2020)
Table 87. North America In Vitro Diagnostic/IVD Revenue by Countries (2015-2020)
Table 88. North America In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)
Table 89. Europe In Vitro Diagnostic/IVD Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific In Vitro Diagnostic/IVD Revenue (Million USD) by Countries (2015-2020)
Table 91. South America In Vitro Diagnostic/IVD Revenue by Countries (2015-2020)
Table 92. South America In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa In Vitro Diagnostic/IVD Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)
Table 95. Global In Vitro Diagnostic/IVD Revenue (Million USD) by Type (2015-2020)
Table 96. Global In Vitro Diagnostic/IVD Revenue Share by Type (2015-2020)
Table 97. Global In Vitro Diagnostic/IVD Revenue Forecast by Type (2021-2025)
Table 98. Global In Vitro Diagnostic/IVD Revenue by Application (2015-2020)
Table 99. Global In Vitro Diagnostic/IVD Revenue Share by Application (2015-2020)
Table 100. Global In Vitro Diagnostic/IVD Revenue Forecast by Application (2021-2025)
Table 101. Global In Vitro Diagnostic/IVD Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. In Vitro Diagnostic/IVD Picture
Figure 2. Global In Vitro Diagnostic/IVD Revenue Market Share by Type in 2019
Figure 3. Instruments Picture
Figure 4. Reagents Picture
Figure 5. In Vitro Diagnostic/IVD Revenue Market Share by Application in 2019
Figure 6. Diabetes Picture
Figure 7. Oncology Picture
Figure 8. Cardiology Picture
Figure 9. Nephrology Picture
Figure 10. Global In Vitro Diagnostic/IVD Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global In Vitro Diagnostic/IVD Revenue Share by Players in 2019
Figure 18. Global Top 5 Players In Vitro Diagnostic/IVD Revenue Market Share in 2019
Figure 19. Global Top 10 Players In Vitro Diagnostic/IVD Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global In Vitro Diagnostic/IVD Revenue Market Share by Regions (2015-2020)
Figure 23. Global In Vitro Diagnostic/IVD Revenue Market Share by Regions in 2018
Figure 24. North America In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 25. Europe In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 27. South America In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 29. North America In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)
Figure 30. North America In Vitro Diagnostic/IVD Revenue Market Share by Countries in 2019
Figure 31. USA In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 32. Canada In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 33. Mexico In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 34. Europe In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)
Figure 35. Europe In Vitro Diagnostic/IVD Revenue Market Share by Countries in 2019
Figure 36. Germany In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 37. UK In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 38. France In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 39. Russia In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 40. Italy In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific In Vitro Diagnostic/IVD Revenue Market Share by Countries in 2019
Figure 43. China In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 44. Japan In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 45. Korea In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 46. India In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 48. South America In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)
Figure 49. South America In Vitro Diagnostic/IVD Revenue Market Share by Countries in 2019
Figure 50. Brazil In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 51. Argentina In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa In Vitro Diagnostic/IVD Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 55. UAE In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 56. Egypt In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 57. South Africa In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)
Figure 58. Global In Vitro Diagnostic/IVD Revenue Share by Type (2015-2020)
Figure 59. Global In Vitro Diagnostic/IVD Revenue Share by Type in 2019
Figure 60. Global In Vitro Diagnostic/IVD Market Share Forecast by Type (2021-2025)
Figure 61. Global Instruments Revenue Growth Rate (2015-2020)
Figure 62. Global Reagents Revenue Growth Rate (2015-2020)
Figure 63. Global In Vitro Diagnostic/IVD Revenue Share by Application (2015-2020)
Figure 64. Global In Vitro Diagnostic/IVD Revenue Share by Application in 2019
Figure 65. Global In Vitro Diagnostic/IVD Market Share Forecast by Application (2021-2025)
Figure 66. Global Diabetes Revenue Growth Rate (2015-2020)
Figure 67. Global Oncology Revenue Growth Rate (2015-2020)
Figure 68. Global Cardiology Revenue Growth Rate (2015-2020)
Figure 69. Global Nephrology Revenue Growth Rate (2015-2020)
Figure 70. Global In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global In Vitro Diagnostic/IVD Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global In Vitro Diagnostic/IVD Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)
Figure 74. Europe In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)
Figure 76. South America In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
体外診断用医薬品（IVD）の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Vitro Diagnostics (IVD) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vitro Diagnostics (IV…- 体外診断用医薬品の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global In-Vitro Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.2% in the forecast period of 2020 to 2025 and will expected to reach USD 71530 million by 2025, from USD 60650 million in 2019. The In-Vitro …
- 体外肺モデルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global In Vitro Lung Model market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 13.6% in the forecast period of 2020 to 2025 and will expected to reach USD 281.3 million by 2025, from USD 169.1 million in 2019. The In Vitro Lung Mod…
- 体外診断（IVD）製品および検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global In Vitro Diagnostics (IVD) Products and Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …
- 体外毒性/毒性試験の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global In-Vitro Toxicology/ Toxicity Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The In-Vitr…